Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

HIV treatment news

Show

From To
European liver specialists recommend 'mix-and-match' approach to new hepatitis C drugs

The European Association for the Study of the Liver (EASL) has issued new guidelines for the treatment of hepatitis C which recommend that wherever possible,

Published
11 April 2014
By
Keith Alcorn
India: Govt HIV treatment programme completes 10 years

The anti-retroviral treatment (ART) covers 768,000 people but challenges in tackling the AIDS virus remain.

Published
11 April 2014
From
Live Mint
Twenty years after genocide, Rwanda is a model of health equity

Just two decades later, life expectancy has doubled. Vaccination rates for many diseases are now higher than those registered in the United States—more than 97% of Rwandan infants are immunized against ten different diseases. Child mortality has fallen by more than two thirds since 2000. New HIV infection rates fell by 60% between 2000 and 2012, and AIDS-related mortality fell by 82%. HIV treatment is free.

Published
10 April 2014
From
Quartz
Nano-sized drug particles to expand HIV treatment further

Research at the University of Liverpool could benefit millions of HIV patients in developing countries through a nano-technology programme aimed at making drug treatment more effective.

Published
09 April 2014
From
Medical Xpress
Giving treatment to specific high-risk people may bring down HIV faster than distributing it equally

In a concentrated epidemic, HIV is mainly restricted to – or at least more common in – specific risk groups. In this situation, and if universal

Published
08 April 2014
By
Gus Cairns
Long-acting HIV drugs advanced to overcome adherence challenge

If it proves effective, long-acting antiretroviral therapy would set up a new paradigm of monthly or quarterly injectable therapy for some patients. Long-acting drug formulations could solve one of the thorniest problems in HIV management - adherence.

Published
08 April 2014
From
Nature Medicine
Better Late Than Never: Efavirenz Dose Optimization

After a study suggests that we’ve been using too high a dose of efavirenz for a decade and a half, the move toward scaling up a lower and more cost-effective one faces some hurdles.

Published
03 April 2014
From
Treatment Action Group
Quality of life for people with HIV in the UK remains poor, despite treatment successes

Compared to the general population, people with HIV experienced lower HRQoL in all of the areas they were questioned about, but especially anxiety and depression. Being female, non-white, without children and having a lower level of education were associated with lower HRQoL. The negative effect of HIV on overall HRQoL was similar to heavy smoking.

Published
02 April 2014
From
British HIV Association
Viiv Healthcare licenses dolutegravir (Tivicay) to Medicines Patent Pool

The collaboration with MPP includes two distinct approaches to improve access for adults living with HIV in the developing world: first, a royalty-free voluntary licence in all least-developed, all low-income and all sub-Saharan African countries; second, for specific middle-income countries including India, ViiV Healthcare has established the first-ever MPP licence with a tiered royalty structure, where a small percentage of the sale price is paid based on the gross domestic product (GDP) of the specific country.

Published
02 April 2014
From
Viiv Healthcare press release
Janssen Submits New Drug Application to U.S. FDA for a Fixed-Dose Combination Tablet of HIV-1 Medicine Darunavir with Cobicistat as Part of Combination HIV Therapy

"Darunavir is the most prescribed HIV protease inhibitor in the United States and we are excited to be taking this important step in our efforts to offer it with an alternative boosting agent in a fixed-dose combination tablet," said Johan van Hoof, M.D., Therapeutic Area Head, Infectious Diseases and Vaccines, Janssen.

Published
02 April 2014
From
Janssen press release

Filter by country